5 Best Revenue Growth Stocks to Buy

3. Shockwave Medical, Inc. (NASDAQ:SWAV)

Number of Hedge Fund Investors In Q1 2023: 28

Shockwave Medical, Inc. (NASDAQ:SWAV) designs and develops catheters that are used to treat patients with heart disease. Its sales have been consistently growing over the past five years, with an average growth rate of 209%. The firm has also comfortably beat analyst EPS estimates for its past four quarters.

28 of the 943 hedge funds part of Insider Monkey’s Q1 2023 database had held a stake in the firm. Out of these, Shockwave Medical, Inc. (NASDAQ:SWAV)’s biggest shareholder is Paul Marshall and Ian Wace’s Marshall Wace LLP since it owns a stake worth $136 million.

Follow Shockwave Medical Inc. (NASDAQ:SWAV)